Department of Medicine 3 – Rheumatology and Immunology

Bone Mass, Bone Microstructure and Biomechanics in Patients with Hand Osteoarthritis (2020) Simon D, Tascilar K, Unbehend S, Bayat S, Berlin A, Liphardt AM, Meinderink T, et al. Journal article Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography (2020) Whittier DE, Boyd SK, Burghardt AJ, Paccou J, Ghasem-Zadeh A, Chapurlat R, Engelke K, Bouxsein ML Journal article The α7 Nicotinic Acetylcholine Receptor: A Promising Target for the Treatment of Fibrotic Skin Disorders (2020) Stegemann A, Flis D, Ziolkowski W, Distler J, Steinbrink K, Böhm M Journal article Regions at Risk in the Knee Joint of Young Professional Soccer Players: Longitudinal Evaluation of Early Cartilage Degeneration by Quantitative T2 Mapping in 3 T MRI (2020) Schenker H, Simon D, Waldenmeier L, Evers C, Janka RM, Welsch GH, Pachowsky M Journal article Microbiota and metabolites in rheumatic diseases (2020) Tong Y, Marion T, Schett G, Luo Y, Liu Y Journal article, Review article Autologous hematopoietic stem cell transplantation for systemic sclerosis: Position statement of the stem cell therapy working party of the German Society of Rheumatology Autologe hämatopoetische Stammzelltransplantation bei systemischer Sklerose: Positionspapier des Arbeitskreises Stammzelltherapie der Deutschen Gesellschaft für Rheumatologie (2020) Alexander T, Henes J, Distler J, Schmalzing M, Blank N, Kötter I, Hiepe F Journal article, Review article COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (2020) Schett G, Sticherling M, Neurath M Journal article Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution B-lymphocyte hyperactivation and autoantibody production in the pathophysiology of cutaneous systemic sclerosis Hiperactivación del linfocito B y producción de los autoanticuerpos anticentrómero, antitopoisomerasa-I, anti-ARNPol-III en la fisiopatología de la esclerosis sistémica cutánea (2020) Hernández-Flórez D, Martínez-Barrio J, López-Longo FJ, Valor L Journal article Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs (2020) Zhang M, Haughey M, Wang NY, Blease K, Kapoun AM, Couto S, Belka I, et al. Journal article